首页|柴芍胃康汤联合四联疗法治疗肝胃气滞证Hp阳性慢性萎缩性胃炎的疗效观察

柴芍胃康汤联合四联疗法治疗肝胃气滞证Hp阳性慢性萎缩性胃炎的疗效观察

扫码查看
目的:观察柴芍胃康汤联合四联疗法治疗肝胃气滞证幽门螺杆菌(Hp)阳性慢性萎缩性胃炎(CAG)的疗效及对患者胃泌素-17(G-17)、丙二醛(MDA)、胃蛋白酶原(PG)Ⅰ和PGⅡ水平,胃黏膜组织病理和Hp根除的影响。方法:选取 2021 年 6 月至2023 年 5 月该院收治的肝胃气滞证Hp阳性CAG患者 140 例,按随机数字表法分为联合组和对照组(各 70 例)。对照组患者给予标准四联疗法,联合组患者在对照组的基础上给予柴芍胃康汤治疗。比较两组患者治疗前后血清G-17、MDA、PGⅠ和PGⅡ水平,胃黏膜组织病理评分、Hp根除率,观察安全性和临床疗效。结果:治疗后,两组患者血清 G-17、PGⅠ水平明显升高,MDA、PGⅡ水平和胃黏膜组织病理评分明显降低;且联合组患者血清G-17、PGⅠ水平较对照组升高,MDA、PGⅡ水平和胃黏膜组织病理评分较对照组降低,差异均有统计学意义(P<0。05)。联合组患者的 Hp 根除率、总有效率分别为 92。86%(65/70)、92。86%(65/70),明显高于对照组的 81。43%(57/70)、81。43%(57/70),差异均有统计学意义(P<0。05)。结论:柴芍胃康汤联合四联疗法治疗肝胃气滞证Hp阳性CAG的疗效较好,可改善患者胃功能、氧化应激和胃黏膜组织病理损伤,并可有效提高Hp根除率。
Efficacy of Chaishao Weikang Decoction Combined with Quadruple Therapy on Helicobacter Pylori Positive Chronic Atrophic Gastritis of Liver Stomach Qi Stagnation Syndrome
OBJECTIVE:To observe the efficacy of Chaishao Weikang decoction combined with quadruple therapy on Helicobacter pylori(Hp)positive chronic atrophic gastritis(CAG)of liver stomach Qi stagnation syndrome and its effects on levels of gastrin 17(G-17),malondialdehyde(MDA),pepsinogen(PG)Ⅰ,PGⅡ,gastric mucosa tissue pathology and eradication of Hp.METHODS:A total of 140 patients with Hp positive CAG of liver stomach Qi stagnation syndrome admitted into Handan Traditional Chinese Medicine Hospital from Jun.2021 to May 2023 were extracted to be divided into the combined group and control group(with 70 cases in each group)via random number table method.The control group was given standard quadruple therapy,while combined group received Chaishao Weikang decoction on the basis of the control group.Serum levels of G-17,MDA,PGⅠand PGⅡ,gastric mucosal histopathological score,Hp eradication rate before and after treatment of two groups were compared,safety and clinical efficacy were observed.RESULTS:After treatment,serum levels of G-17 and PGⅠ increased significantly,while levels of MDA and PGⅡ and gastric mucosal histopathologic scores decreased significantly in two groups;and serum levels of G-17 and PGⅠ in combined group were higher than those in control group,while levels of MDA and PGⅡand gastric mucosal histopathologic scores were lower than those in control group,with statistically significant differences(P<0.05).The eradication rate and total effective rate of Hp in combined group were respectively 92.86%(65/70)and 92.86%(65/70),significantly higher than 81.43%(57/70)and 81.43%(57/70)in control group,the differences were statistically significant(P<0.05).CONCLUSIONS:The efficacy of Chaishao Weikang decoction combined with quadruple therapy on Hp positive CAG of liver stomach Qi stagnation syndrome is significant,which can improve gastric function,oxidative stress,and pathological damage to gastric mucosa tissue,and effectively increase the Hp eradication rate.

Chaishao Weikang decoctionQuadruple therapyLiver stomach Qi stagnation syndromeHelicobacter pylori positiveChronic atrophic gastritisClinical efficacy

王维、张瑜、孙胜振、华元鑫

展开 >

邯郸市中医院治未病中心,河北 邯郸 056002

邯郸市中医院脾胃病科,河北 邯郸 056002

柴芍胃康汤 四联疗法 肝胃气滞证 幽门螺杆菌阳性 慢性萎缩性胃炎 临床疗效

河北省中医药类科研指令性计划

2021470

2024

中国医院用药评价与分析
中国医药生物技术协会,中国药房杂志社

中国医院用药评价与分析

CSTPCD
影响因子:1.142
ISSN:1672-2124
年,卷(期):2024.24(3)
  • 21